BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 24984296)

  • 21. Expression assessment of a panel of long non-coding RNAs in gastric malignancy.
    Esfandi F; Salehnezhad T; Taheri M; Afsharpad M; Hafez AA; Oskooei VK; Ghafouri-Fard S
    Exp Mol Pathol; 2020 Apr; 113():104383. PubMed ID: 31982396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long non-coding RNA ZEB2-AS1 expression is associated with disease progression and predicts outcome in gastric cancer patients.
    Xu C; Cui H; Li H; Wu Y; An H; Guo C
    J BUON; 2019; 24(2):663-671. PubMed ID: 31128021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased Expression of Lncrna RP11-397A15.4 in Gastric Cancer and Its Clinical Significance.
    Chen H; Xu Z; Liu X; Gao Y; Wang J; Qian P; Yang B
    Ann Clin Lab Sci; 2018 Nov; 48(6):707-711. PubMed ID: 30610039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of the long noncoding RNA RP11-19P22.6-001 in gastric cancer.
    Sun W; Mo X; Li T; Xie Y; Guo J
    Cancer Biomark; 2017; 18(4):397-403. PubMed ID: 28128738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating lncRNA ABHD11-AS1 serves as a biomarker for early pancreatic cancer diagnosis.
    Liu Y; Feng W; Liu W; Kong X; Li L; He J; Wang D; Zhang M; Zhou G; Xu W; Chen W; Gong A; Xu M
    J Cancer; 2019; 10(16):3746-3756. PubMed ID: 31333792
    [No Abstract]   [Full Text] [Related]  

  • 26. Long noncoding RNA FEZF1-AS1 indicates a poor prognosis of gastric cancer and promotes tumorigenesis via activation of Wnt signaling pathway.
    Wu X; Zhang P; Zhu H; Li S; Chen X; Shi L
    Biomed Pharmacother; 2017 Dec; 96():1103-1108. PubMed ID: 29239821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced expression of the long non-coding RNA AI364715 in gastric cancer and its clinical significance.
    Zhu S; Mao J; Shao Y; Chen F; Zhu X; Xu D; Zhang X; Guo J
    Tumour Biol; 2015 Sep; 36(10):8041-5. PubMed ID: 25971582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upregulated expression of MNX1-AS1 long noncoding RNA predicts poor prognosis in gastric cancer.
    Zhang W; Huang L; Lu X; Wang K; Ning X; Liu Z
    Bosn J Basic Med Sci; 2019 May; 19(2):164-171. PubMed ID: 30821221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Up-regulation of SUMO1 pseudogene 3 (SUMO1P3) in gastric cancer and its clinical association.
    Mei D; Song H; Wang K; Lou Y; Sun W; Liu Z; Ding X; Guo J
    Med Oncol; 2013 Dec; 30(4):709. PubMed ID: 23996296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulation of the long noncoding RNAs DSCAM-AS1 and MANCR is a potential diagnostic marker for breast carcinoma.
    Tahmouresi F; Razmara E; Pakravan K; Mossahebi-Mohammadi M; Rouhollah F; Montazeri M; Sarrafzadeh A; Fahimi H; Babashah S
    Biotechnol Appl Biochem; 2021 Dec; 68(6):1250-1256. PubMed ID: 33012018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long noncoding RNA NNT-AS1 promotes gastric cancer proliferation and invasion by regulating microRNA-363 expression.
    Wang X; Ren M; Li Y; Hu J; Lu G; Ma W; Guo D; Lu X; He S
    J Cell Biochem; 2019 Apr; 120(4):5704-5712. PubMed ID: 30324628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DICER-AS1 lncRNA: A putative culprit in the pathogenesis of gastric cancer.
    Afrough H; Ghafouri-Fard S; Yousefi H; Pakzad P; Kholghi Oskooei V; Taheri M
    Exp Mol Pathol; 2020 Oct; 116():104490. PubMed ID: 32663487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MAFG-AS1 is a novel clinical biomarker for clinical progression and unfavorable prognosis in gastric cancer.
    Li C; Wu R; Xing Y
    Cell Cycle; 2020 Mar; 19(5):601-609. PubMed ID: 32079456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. STAT3-induced upregulation of lncRNA ABHD11-AS1 promotes tumour progression in papillary thyroid carcinoma by regulating miR-1301-3p/STAT3 axis and PI3K/AKT signalling pathway.
    Wen J; Wang H; Dong T; Gan P; Fang H; Wu S; Li J; Zhang Y; Du R; Zhu Q
    Cell Prolif; 2019 Mar; 52(2):e12569. PubMed ID: 30657221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long non-coding RNA UCA1 may be a novel diagnostic and predictive biomarker in plasma for early gastric cancer.
    Gao J; Cao R; Mu H
    Int J Clin Exp Pathol; 2015; 8(10):12936-42. PubMed ID: 26722487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long intergenic non-protein coding RNA 1006 used as a potential novel biomarker of gastric cancer.
    Zhu X; Chen F; Shao Y; Xu D; Guo J
    Cancer Biomark; 2017 Dec; 21(1):73-80. PubMed ID: 29060927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Downregulated Expression of linc-ROR in Gastric Cancer and Its Potential Diagnostic and Prognosis Value.
    Yu X; Ding H; Shi Y; Yang L; Zhou J; Yan Z; Xiao B
    Dis Markers; 2020; 2020():7347298. PubMed ID: 33163123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long Noncoding RNA GMAN, Up-regulated in Gastric Cancer Tissues, Is Associated With Metastasis in Patients and Promotes Translation of Ephrin A1 by Competitively Binding GMAN-AS.
    Zhuo W; Liu Y; Li S; Guo D; Sun Q; Jin J; Rao X; Li M; Sun M; Jiang M; Xu Y; Teng L; Jin Y; Si J; Liu W; Kang Y; Zhou T
    Gastroenterology; 2019 Feb; 156(3):676-691.e11. PubMed ID: 30445010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long non-coding RNA expression profile in human gastric cancer and its clinical significances.
    Song H; Sun W; Ye G; Ding X; Liu Z; Zhang S; Xia T; Xiao B; Xi Y; Guo J
    J Transl Med; 2013 Sep; 11():225. PubMed ID: 24063685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exosomal long noncoding RNA lnc-GNAQ-6:1 may serve as a diagnostic marker for gastric cancer.
    Li S; Zhang M; Zhang H; Hu K; Cai C; Wang J; Shi L; Ma P; Xu Y; Zheng P
    Clin Chim Acta; 2020 Feb; 501():252-257. PubMed ID: 31730812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.